- Increase the production of 6-APA and Amoxicillin to cover 100% of inside need.
- Become the first ranked of Macrolide based products in Iran pharmaceutical market.
- Improving companies’ financial and economic indicators.
- Reduce environmental risks associated with production.
- Portfolio development by adding at least 3 new products per year.
- Increase organization productivity in resource consumption.
- Maximize shareholder wealth as the long term goal.
- Supply orphan drugs and vaccine accord R&D capabilities.
- Production and supply of Penicillin G , Amoxicillin and Macrolide based products in the country according to market demand.
- Countrys’ independency to foreign sources and become completely independent in different type of Antibiotics production.
- Maintain and develop the know-how of the Penicillin G , 6APA and Amoxicillin and macrolides production.
- Supply Covid-19 vaccine
- Conducting researches in the fields of pharmaceutical, technology and marketing and business to achieve the slogan: “Increasing the level of public health for sustainable development to achieve social justice”.